Cartesian Therapeutics reports durable improvements after Descartes-08 retreatment; no new safety signals

Cartesian Therapeutics announced that retreatment with Descartes-08 produced sustained symptom improvements at Month 12 with no new safety signals.Key Highlights:Original SEC Filing: Cartesian Therapeutics, Inc. [ RNAC ] - 8-K - Sep. 29, 2026This is an AI-powered summary. It may contain inaccuracie…